Lantheus Holdings Inc 's ROA from the third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics

What is Lantheus Holdings Inc 's ROA in the third quarter of 2026?
Lantheus Holdings Inc achieved a return on average assets (ROA) of 11.61 % in its third quarter of 2026, this is above LNTH's average return on assets of 10.25%.
Lantheus Holdings Inc s assets during the 12 months ending in the third quarter of 2026 are valued at $2 billion

ROA decreased relative to the period ending Jun 30 2026, due to the decline in net income.

However, within the Healthcare sector 83 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2026 quarter, so far to 475, from total ROA ranking in the second quarter of 2026 at 638.

What is ROA?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Assets ROA▼

None ▼

Return on Assets ROA▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Assets	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Total Assets Change	6.71 %	12.87 %	9.7 %	22.95 %	19.4 %
Y / Y Net Income Change	-19.44 %	-4.73 %	62.34 %	-	-78.82 %
Net Income (TTM) in million	270	275	279	234	168
Return On Assets (TTM)	11.61 %	12.04 %	12.58 %	10.77 %	8.12 %
LNTH's Total Ranking	# 475	# 638	# 782	# 415	# 445
Total Assets (TTM) in million	2,429	2,388	2,254	2,227	2,276
Seq. Total Assets Change	1.7 %	5.94 %	1.22 %	-2.15 %	7.58 %
Seq. Net Income Change	-70.18 %	-36.64 %	118.93 %	94.76 %	-64.74 %

LNTH's 5 Years Annual ROA >> Back to LNTH Management Effectiveness >> Compare LNTH ROA to its Competitors

Return On Assets Company Ranking
Within:	No.
Industry	# 2
Sector	# 84
Overall	# 524

Return On Assets Statistics
High	Average	Low
41.74 %	10.25 %	-8.35 %
(Dec 31 2017)		(Dec 31 2021)

News about Lantheus Holdings Inc Return on Assets ROA

Lantheus Celebrates CMS Payment Enhancements for Radiopharmaceuticals as PYLARIFY Set to Dominate 2025 Market,

Lantheus Applauds CMS 2025 Payment Rule Enhancements for Diagnostic Radiopharmaceuticals: PYLARIFY Positioned for Continued SuccessLantheus Holdings, Inc. a key player in the radiopharmaceutical industry, has recently expressed its commendation for the Centers for Medicare and Medicaid Services (CMS) decision to enhance payment structures related to specialized diagnostic radiopharmaceuticals for the calendar year 2025. This adjustment, highlighted in the final rule for the Medicare Hospital Outpatient Prospective Payment System (OPPS), marks a significant step toward improving patient access to essential diagnostic services. Enhanced Payment Rates and Improved AccessCMS s updated payment rates, posted in Addendum B, demonstrate a recognition of the unique value and necessity of specialized diagnostic radiopharmaceuticals. These agents are pivotal in accurately diagnosing and managing diseases, contributing to significant improvements in patient outcomes. Lantheus argues that by refining the payment structure, healthcare facilities can bolster their financial viability while ensuring that patients have greater access to cutting-edge diagnostic technologies.

Financial Statements
Lantheus Holdings Inc 's Assets	$ 2,429 million	LNTH's Balance sheet
Lantheus Holdings Inc 's Income	$ 22 million	Quarterly LNTH's Income Statement
LNTH's Income by Division		See LNTH's Income by Division

Annual Return On Assets	(Dec 31 2025) FY 2025	(Dec 31 2024) FY 2024	(Dec 31 2023) FY 2023	(Dec 31 2022) FY 2022	(Dec 31 2021) FY 2021
Y / Y Total Assets Change	22.95 %	20.53 %	24 %	51.04 %	0.33 %
Total Assets in million	2,227	1,812	1,503	1,212	802
Y / Y Net Income Change	-25.25 %	-4.35 %	1063.86 %	-	-
Net Income in million	234	312	327	28	-71
Annual Return On Assets	10.49 %	17.25 %	21.73 %	2.32 %	-8.88 %

LNTH's 5 Years Annual ROA >> Back to LNTH Management Effectiveness >> Compare LNTH ROA to its Competitors

Comment on LNTH's ROA in the fiscal year ending 2025

In the fiscal year 2025 Lantheus Holdings Inc 's ROA decreased compared to previous year to 10.49 %, due to deterioration of net income -25.25 % to $233.56 million, from $312.44 million a year ago, as LNTH's assets were $2,227.40 million.

More Return On Assets Ratios
LNTH's' Return on Assets at Yahoo Finance
In Vitro & In Vivo Diagnostic Substances Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
LNTH's Roa Ratio versus In Vitro & In Vivo Diagnostic Substances Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for LNTH's Competitors
Subscribers only: Roa for Lantheus Holdings Inc 's Suppliers
Subscribers only: Return On Assets for LNTH's Customers

You may also want to know
LNTH's Roi	LNTH's Inventory Turnover Ratio	LNTH's Growth Rates	LNTH's Dividend Comparisons
	LNTH's Profitability Ratios	LNTH's Asset Turnover Ratio	LNTH's Dividend Growth
LNTH's Roe	LNTH's Valuation Ratios	LNTH's Financial Strength Ratios	LNTH's Dividend Payout Ratio

Companies with similar Return On Assets at Sep 30 2026, within Healthcare Sector	ROA
Zevra Therapeutics Inc	26.33 %
Caredx Inc	25.74 %
Medpace Holdings Inc	24.47 %
Acadia Pharmaceuticals Inc	21.60 %
Standard Biotools Inc	21.56 %
Eli Lilly And Company	21.24 %
Iradimed Corporation	20.89 %
Resmed Inc	18.67 %
Alector Inc	18.37 %
Corcept Therapeutics Inc	18.09 %
Chemed Corporation	17.73 %
Halozyme Therapeutics Inc	17.26 %
Pro dex Inc	16.75 %
Denali Therapeutics Inc	16.42 %
Krystal Biotech Inc	15.48 %
West Pharmaceutical Services Inc	15.47 %
Dexcom Inc	15.47 %
Intuitive Surgical Inc	14.71 %
Vertex Pharmaceuticals Inc	14.16 %
Neurocrine Biosciences Inc	13.69 %
Illumina Inc	13.43 %
Healthcare Services Group Inc	12.79 %
Kiniksa Pharmaceuticals International Plc	12.64 %
Tenet Healthcare Corp	12.39 %
Hca Healthcare Inc	11.73 %
Carlisle Companies Incorporated	11.72 %
Regeneron Pharmaceuticals Inc	11.50 %
Lantheus Holdings Inc	11.43 %
Msa Safety Inc	11.01 %
Encompass Health Corporation	10.99 %

Date modified: 2026-11-09T06:46:05+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.